These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35099994)

  • 1. In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d.
    Bikdeli B; Garcia DA
    Ann Intern Med; 2022 Feb; 175(2):JC17. PubMed ID: 35099994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d.
    Bikdeli B; Garcia DA
    Ann Intern Med; 2022 Feb; 175(2):JC16. PubMed ID: 35099997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and SARS-CoV-2: Multiple Pathophysiological Links.
    Di Micco P; Imbalzano E; Russo V; Attena E; Mandaliti V; Orlando L; Lombardi M; Di Micco G; Camporese G; Annunziata S; Piccinocchi G; Pacelli W; Del Guercio M
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
    Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
    Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
    Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
    Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [COVID-19, anticoagulation and venous thromboembolism: what have we learned ?].
    Blondon M; Robert-Ebadi H
    Rev Med Suisse; 2021 Dec; 17(762):2140-2144. PubMed ID: 34878743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intermediate/high versus low dose heparin on the thromboembolic and hemorrhagic risk of unvaccinated COVID-19 patients in the emergency department.
    Marchioni C; Esposito G; Calci M; Bais B; Colussi G
    BMC Emerg Med; 2022 Jun; 22(1):107. PubMed ID: 35698054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    Goligher EC; Lawler PR; Jensen TP; Talisa V; Berry LR; Lorenzi E; McVerry BJ; Chang CH; Leifer E; Bradbury C; Berger J; Hunt BJ; Castellucci LA; Kornblith LZ; Gordon AC; McArthur C; Webb S; Hochman J; Neal MD; Zarychanski R; Berry S; Angus DC;
    JAMA; 2023 Apr; 329(13):1066-1077. PubMed ID: 36942550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis in hospitalized COVID-19 patients: the efficacy and safety of the approved hospital protocol.
    Kolanko E; Senderek T; Prokop-Staszecka A; Kruk A; Broniatowska E; Konieczyńska M; Kopiński P; Pudło J; Undas A
    Pol Arch Intern Med; 2021 Oct; 131(10):. PubMed ID: 34605232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports.
    Kyriakoulis KG; Kollias A; Kyriakoulis IG; Kyprianou IA; Papachrysostomou C; Makaronis P; Kotronias RA; Terentes-Printzios D; Toskas I; Mikhailidis DP
    Curr Vasc Pharmacol; 2022; 20(1):96-110. PubMed ID: 34431465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
    Shalhoub J; Lawton R; Hudson J; Baker C; Bradbury A; Dhillon K; Everington T; Gohel MS; Hamady Z; Hunt BJ; Stansby G; Warwick D; Norrie J; Davies AH
    Health Technol Assess; 2020 Dec; 24(69):1-80. PubMed ID: 33275096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
    Iba T; Connors JM; Spyropoulos AC; Wada H; Levy JH
    Int J Hematol; 2021 Mar; 113(3):330-336. PubMed ID: 33471294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients.
    Jonmarker S; Litorell J; Dahlberg M; Stackelberg O; Everhov ÅH; Söderberg M; Rubenson-Wahlin R; Günther M; Mårtensson J; Hollenberg J; Joelsson-Alm E; Cronhjort M
    Acta Anaesthesiol Scand; 2022 Mar; 66(3):365-374. PubMed ID: 34875111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
    Cattaneo M; Bertinato EM; Birocchi S; Brizio C; Malavolta D; Manzoni M; Muscarella G; Orlandi M
    Thromb Haemost; 2020 Aug; 120(8):1230-1232. PubMed ID: 32349132
    [No Abstract]   [Full Text] [Related]  

  • 19. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
    Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.